Clinical research - Articles
About Tumor Suppressor Genes A tumor suppressor gene, also known as anti-onco gene, is an essential component of the body's defense against cancer. It usually facilitates apoptosis. With its absence, the human body will be functioning without its “brake” of cell proliferation. Cells are potent to go under abnormal growth processes and finally lead to tumor/cancer. Here are some key features and functions of tumor suppressor genes: Inhibition of Cell Growth:…
Electronic Data Capture (EDC) software has revolutionized clinical trials, enabling clinical research teams to streamline data management and enhance operational efficiency. However, the true potential of EDC is realized when coupled with advanced features that leverage artificial intelligence (AI) and machine learning (ML). Among the sea of options, Clinion EDC stands out as a game-changer. Discover how Clinion EDC’s advanced AI-enabled features like eProtocol Automation, Global Libraries, AI Medical Coding and Remote SDV Automation set it apart from the competition, making it the ideal choice for accelerating your tr…
Interleukin-2 (IL-2) is a 15kDa secretory protein with a 4-alpha-helical bundle structure. As a T-cell related growth factor, IL-2 can enhance the killing activity of NK cells and promote B cells to produce immunoglobulins. In addition, it aids i…
Autoimmune disease target - IL-17 Family IL-17 plays an important role in promoting autoimmune diseases such as psoriasis, psoriatic arthritis, and ankylosing spondylitis (AS). Currently, five large-molecule biopharmaceuticals targeting IL-17/IL-17R are available worldwide, including four IL-17 monoclonal antibodies and one IL-17RA monoclonal antibody, namely Secukinumab(Novartis), Ixekizumab(Eli Lilly), Netakimab(Biocad), Brodalumab(Kyowa Hakko Kirin), and Bimekizumab(UCB). &nbs…
Tumors and Blood Vessel Growth Tumor, as an abnormal mass of cells, has blood vessels of various sizes that can be seen everywhere on the surface and deep within it. Nutrients for life are continuously supplied to the depths of tumor cells through these blood vessels. As the tumor continues to grow, nearby bloo…
The MMP Family Matrix metalloproteinases (MMPs) are a family of enzymes belonging to the metzincin superfamily. There are 23 different types of secreted or membrane-anchored endopeptidases in the human body. MMPs are capable of degrading ECM proteins such as collagen, gelatin, laminin, fibronectin, fibrinogen, elastin, and proteoglycans. They were once considered regulators of the extracellular matrix. MMPs have multiple structural domains, including a signal peptide (…
Introduction:- Good Clinical Practice (GCP) guidelines form the backbone of ethical and high-quality Clinical research by TechnoBridge. These guidelines establish internationally recognized standards for the design, conduct, and reporting of clinical trials involving human participants. In this article, we explore the importance of GCP guidelines in safeguarding participant rights and ensuring data i…
IL-36, A Member of IL-1 Superfamily, Emerging Target for Treating Inflammatory Diseases Introduction to IL-36 Family Twenty years ago, Interleukin 36 (IL-36) was discovered as a member of the IL-1 superfamily. Its gene is located on chromosome 2 in an IL gene cluster, including IL1A - IL1B - IL37 - IL36G - IL36A - IL36B - IL36RN - IL38 - IL1RN, with IL-36 encoding genes transcribed far away from the centromere. There are four known subtypes of IL-36, which have been renamed multiple times…
Mechanisms of NK Cell Activation NK cells are regulated by a dynamic balance between a series of activating and inhibitory receptors. Normal cells express major histocompatibility complex class…
TSLP and TSLPR TSLP (Thymic Stromal Lymphopoietin) is a member of the four-helix bundle cytokine family and is a distant homolog of IL-7. As the name suggests, TSLP was initially identified in the mouse thymic stromal cell line Z210R, as a factor that promotes the proliferation and development of immature B cells. Subsequently, TSLP was found to…
The biologics license application (BLA) has been accepted for Enfortumab Vedotin for the treatment of locally advanced or metastatic urothelial carcinoma in patients who have previously received PD-1/PD-L1 inhibitors and platinum-containing chemotherapy. Enfortumab Vedotin is the first domestically submitted targeted an…
Are you in a situation where you are planning to select an eClinical platform for your trials?You are not alone; many clinical research organizations are in the same boat. If you have ever scoured the internet to find out which Software to use for your clinical trials, you could be overwhelmed by the number of options available. In this post, we will help make your job easier by offering a list of essential features that your eClinical platform should have. If you already have a preferred eClinical solution in mind, then it is best to evaluate them against these criteria before making a final decision. If you do not have any preferences yet, th…
AI (Artificial Intelligence) and automation are increasingly being used in various industries, including the pharmaceutical and biotech industries, to improve efficiency, and accuracy, and speed up the drug development process. AI and automation in clinical trials can play a significant role in streamlining the process, reducing costs, and improving patient outcomes. Here are some ways AI and automation are being used in clinical trials: Patient recruitment: AI-powered tools can be used to analyze patient data and identify individuals who meet the criteria for a particular clinical trial. This c…
Low Endotoxin Cytokines Matters Organoid culture, CAR-T cell therapy, stem cell therapy, and other topics have become broadly discussed among biomedical researchers. In fact, it is not difficult to see that these advanced technologies are all related to cell culture. In order to maintain efficient growth, proliferation, and differentiation during in vitro cell culture, many cell cultures require the addition of various cytokines. Cytokines Backgrounds Cytokines are proteins synthesized and secreted by immune cells such as monocytes/macrophages and certain non-i…
In recent years, medical research and innovation have witnessed remarkable advancements in the field of immunotherapy, specifically in the realm of T-cell therapy. T-cell therapy is an emerging form of cancer treatment that harnesses the body's own immune system to target and eliminate cancer cells. This groundbreaking approach holds immense promise for patients battling various types of cancer and has the potential to revolutionize the landscape of cancer treatment. At the core of T-cell therapy lies th…
Background: Across Europe, we continue to see a declining trend in the number of clinical trials taking place, most notably since the European Union Clinical Trials Directive (CTD) was established in 2004. The decline in clinical trials in Ireland is a major concern, as it means that fewer people are given acces…
As an enzyme that has several applications in the field of biotech, Tn5 transposase, a bacterial transposase working in a “cut-and- paste” mode with amplification, can insert specific DNA sequences into a variety of substrates, including plasmids, bacterial chromosomes, and artificial DNA constructs. The following content will introduce the usage method of Tn5 transposase and the application of Tn5 transposase into genomic research and pharmaceuticals. To get ready for any further application, T…
How can cells of the human body respond quickly to physical and chemical changes in their environment? Although genetic mutations can cause changes to the properties of a cell, non-genetic mechanisms can drive rapid adaptation, in a process broadly termed cell plasticity. Cell plasticity is involved in fundamental biological processes in health and dise…
Clinical research is a branch of health sciences. It aims to detect, analyze, treat, and prevent diseases. An example is the continuous research into cancer. The search for a cure or treatment is ongoing. The biggest challenge in clinical research was processing large amounts of data. It was a process that would ofte…
The potential of life sciences to deliver game-changing medicines and technology has never been greater. And with discoveries will come high numbers of jobs and significant economic benefits. That is exciting news in a sector that already employs more than 250,000 people, supports 6,500 businesses, and generates an annual turnover of £94bn. (1) With increased funding from UK Life Sciences and the L…